Regulation of VEGF-expression by patupilone and ionizing radiation in lung adenocarcinoma cells

Lung Cancer

Volumn 73, Issue 3, 2011, Pages 294-301

  Rohrer Bley, Carla ^a,b   Orlowski, Katrin ^a   Furmanova, Polina ^a   McSheehy, Paul M J ^c   Pruschy, Martin ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

A549 lung adenocarcinoma cells; Angiogenesis; Hypoxia; Ionizing radiation; Microtubules; Patupilone; VEGF

Indexed keywords

EPOTHILONE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; VASCULOTROPIN;

ARTICLE; CARCINOMA CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME RELEASE; HUMAN; HUMAN CELL; HYPOXIA; IONIZING RADIATION; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; STRESS; TUMOR VASCULARIZATION; WILD TYPE;

ADENOCARCINOMA; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; EPOTHILONES; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PARACRINE COMMUNICATION; PROTEIN STABILITY; RADIATION, IONIZING; TUBULIN MODULATORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960342262     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.01.010     Document Type: Article

References (27)

1. Altmann K.H., Gertsch J. Anticancer drugs from nature - natural products as a unique source of new microtubule-stabilizing agents. Nat Prod Rep 2007, 24:327-357.
2. Bley C.R., Jochum W., Orlowski K., Furmanova P., Vuong V., McSheehy P.M., et al. Role of the microenvironment for radiosensitization by patupilone. Clin Cancer Res 2009, 15:1335-1342.
3. Escuin D., Kline E.R., Giannakakou P. Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function. Cancer Res 2005, 65:9021-9028.
4. Hofstetter B., Vuong V., Broggini-Tenzer A., Bodis S., Ciernik I.F., Fabbro D., et al. Patupilone acts as radiosensitizing agent in multidrug-resistant cancer cells in vitro and in vivo. Clin Cancer Res 2005, 11:1588-1596.
5. Mabjeesh N.J., Escuin D., LaVallee T.M., Pribluda V.S., Swartz G.M., Johnson M.S., et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 2003, 3:363-375.
6. Altmann K.H., Wartmann M., O'Reilly T. Epothilones and related structures - a new class of microtubule inhibitors with potent in vivo antitumor activity. Biochim Biophys Acta 2000, 1470:M79-91.
7. Kong Z., Raghavan P., Xie D., Boike T., Burma S., Chen D., et al. Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells. Int J Radiat Oncol Biol Phys 2010, 78:1210-1218.
8. Pawlik T.M., Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 2004, 59:928-942.
9. Sinclair W.K. Cyclic X-ray responses in mammalian cells in vitro. Radiat Res 1968, 33:620-643.
10. Thorpe P.E. Vascular targeting agents as cancer therapeutics. Clin Cancer Res 2004, 10:415-427.
11. Bocci G., Nicolaou K.C., Kerbel R.S. Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs. Cancer Res 2002, 62:6938-6943.
12. Ferretti S., Allegrini P.R., O'Reilly T., Schnell C., Stumm M., Wartmann M., et al. Patupilone induced vascular disruption in orthotopic rodent tumor models detected by magnetic resonance imaging and interstitial fluid pressure. Clin Cancer Res 2005, 11:7773-7784.
13. Pasquier E., Honore S., Braguer D. Microtubule-targeting agents in angiogenesis: where do we stand?. Drug Resist Updat 2006, 9:74-86.
14. Dewhirst M.W., Cao Y., Li C.Y., Moeller B. Exploring the role of HIF-1 in early angiogenesis and response to radiotherapy. Radiother Oncol 2007, 83:249-255.
15. Moeller B.J., Cao Y., Li C.Y., Dewhirst M.W. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 2004, 5:429-441.
16. Galmarini C.M. Sagopilone a microtubule stabilizer for the potential treatment of cancer. Curr Opin Investig Drugs 2009, 10:1359-1371.
17. Hanna N., Shepherd F.A., Fossella F.V., Pereira J.R., De Marinis F., von Pawel J., et al. Jr. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 2004, 22:1589-1597.
18. Saloustros E., Mavroudis D., Georgoulias V. Paclitaxel and docetaxel in the treatment of breast cancer. Expert Opin Pharmacother 2008, 9:2603-2616.
19. Giannakakou P., Gussio R., Nogales E., Downing K.H., Zaharevitz D., Bollbuck B., et al. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells. Proc Natl Acad Sci USA 2000, 97:2904-2909.
20. He L., Yang C.P., Horwitz S.B. Mutations in beta-tubulin map to domains involved in regulation of microtubule stability in epothilone-resistant cell lines. Mol Cancer Ther 2001, 1:3-10.
21. Wang Y., O'Brate A., Zhou W., Giannakakou P. Resistance to microtubule-stabilizing drugs involves two events: beta-tubulin mutation in one allele followed by loss of the second allele. Cell Cycle 2005, 4:1847-1853.
22. Stimpfl M., Tong D., Fasching B., Schuster E., Obermair A., Leodolter S., et al. Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer. Clin Cancer Res 2002, 8:2253-2259.
23. Gorski D.H., Beckett M.A., Jaskowiak N.T., Calvin D.P., Mauceri H.J., Salloum R.M., et al. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 1999, 59:3374-3378.
24. Toiyama Y., Inoue Y., Hiro J., Ojima E., Watanabe H., Narita Y., et al. The range of optimal concentration and mechanisms of paclitaxel in radio-enhancement in gastrointestinal cancer cell lines. Cancer Chemother Pharmacol 2007, 59:733-742.
25. Toiyama Y., Inoue Y., Hiro J., Ojima E., Watanabe H., Narita Y., et al. Paclitaxel inhibits radiation induced VEGF secretion and enhances radiosensitizing effects in human colon cancer cell HT29. Cancer Ther 2009, 7:123-132.
26. Schnaeker E.M., Ossig R., Ludwig T., Dreier R., Oberleithner H., Wilhelmi M., et al. Microtubule-dependent matrix metalloproteinase-2/matrix metalloproteinase-9 exocytosis: prerequisite in human melanoma cell invasion. Cancer Res 2004, 64:8924-8931.
27. Fogh S., Machtay M., Werner-Wasik M., Curran W.J., Bonanni R., Axelrod R., et al. Phase I trial using patupilone (epothilone B) and concurrent radiotherapy for central nervous system malignancies. Int J Radiat Oncol Biol Phys 2010, 77:1009-1016.